REVA Medical Considers IPOing Next Year

Published: Nov 23, 2015

Reva Medical (ASX:RVA) is reportedly considering listing its shares on the U.S. stock market next year as it gears up to commercialize its Fantom absorbable stent.

Reva, which is based in San Diego, lists its shares on the Australian stock exchange but is mulling a move to the NASDAQ exchange here, founder & chairman Bob Stockman told the Sydney Morning Herald.

A final decision on a U.S. listing due to be made by mid-2016, Stockman said, after the expected release of follow-up data from a pivotal trial in May.

Back to news